These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants. Abdelnour A, Silas PE, Lamas MR, Aragón CF, Chiu NC, Chiu CH, Acuña TH, Castrejón Tde L, Izu A, Odrljin T, Smolenov I, Hohenboken M, Dull PM. Vaccine; 2014 Feb 12; 32(8):965-72. PubMed ID: 24397906 [Abstract] [Full Text] [Related]
9. Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines. Vesikari T, Forsten A, Bianco V, Van der Wielen M, Miller JM. Pediatr Infect Dis J; 2015 Dec 01; 34(12):e298-307. PubMed ID: 26780033 [Abstract] [Full Text] [Related]
15. Immunogenicity and safety of a single dose of a CRM-conjugated meningococcal ACWY vaccine in children and adolescents aged 2-18 years in Taiwan: results of an open label study. Huang LM, Chiu NC, Yeh SJ, Bhusal C, Arora AK. Vaccine; 2014 Sep 08; 32(40):5177-84. PubMed ID: 25075804 [Abstract] [Full Text] [Related]
16. Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age. Nolan TM, Nissen MD, Naz A, Shepard J, Bedell L, Hohenboken M, Odrljin T, Dull PM. Hum Vaccin Immunother; 2014 Sep 08; 10(2):280-9. PubMed ID: 24220326 [Abstract] [Full Text] [Related]
17. A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents. Jackson LA, Jacobson RM, Reisinger KS, Anemona A, Danzig LE, Dull PM. Pediatr Infect Dis J; 2009 Feb 08; 28(2):86-91. PubMed ID: 19116603 [Abstract] [Full Text] [Related]
18. Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines. Arguedas A, Soley C, Loaiza C, Rincon G, Guevara S, Perez A, Porras W, Alvarado O, Aguilar L, Abdelnour A, Grunwald U, Bedell L, Anemona A, Dull PM. Vaccine; 2010 Apr 19; 28(18):3171-9. PubMed ID: 20189491 [Abstract] [Full Text] [Related]
19. Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers. Bona G, Castiglia P, Zoppi G, de Martino M, Tasciotti A, D'Agostino D, Han L, Smolenov I. Vaccine; 2016 Jun 17; 34(29):3363-70. PubMed ID: 27181507 [Abstract] [Full Text] [Related]
20. Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia. Ilyina N, Kharit S, Namazova-Baranova L, Asatryan A, Benashvili M, Tkhostova E, Bhusal C, Arora AK. Hum Vaccin Immunother; 2014 Jun 17; 10(8):2471-81. PubMed ID: 25424958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]